Newron Pharmaceuticals S.p.A. (FRA:NP5)
9.86
+0.83 (9.19%)
At close: Sep 5, 2025
Newron Pharmaceuticals Employees
Newron Pharmaceuticals had 22 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
22
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
€2,335,909
Profits / Employee
€720,136
Market Cap
198.80M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 22 | 0 | - |
Dec 31, 2023 | 22 | -1 | -4.35% |
Dec 31, 2022 | 23 | -2 | -8.00% |
Dec 31, 2021 | 25 | 2 | 8.70% |
Dec 31, 2020 | 23 | -3 | -11.54% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
SAP SE | 109,121 |
Siemens Aktiengesellschaft | 327,000 |
Deutsche Telekom AG | 198,194 |
Allianz SE | 156,626 |
Rheinmetall AG | 28,539 |
Siemens Energy AG | 98,000 |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
Deutsche Bank Aktiengesellschaft | 89,753 |